These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11783498)

  • 1. 6-mercaptopurine: efficacy and bone marrow toxicity in childhood acute lymphoblastic leukemia. Association with low (thio)purine enzyme activity.
    De Abreu RA; Lambooy LH; Ahment K; Brouwer C; Keizer-Garritsen JJ; Bokkerink JP; Trijbels FJ
    Adv Exp Med Biol; 2000; 486():271-5. PubMed ID: 11783498
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic polymorphisms of thiopurine S-methyltransferase and 6-mercaptopurine toxicity in Japanese children with acute lymphoblastic leukaemia.
    Ando M; Ando Y; Hasegawa Y; Sekido Y; Shimokata K; Horibe K
    Pharmacogenetics; 2001 Apr; 11(3):269-73. PubMed ID: 11337943
    [No Abstract]   [Full Text] [Related]  

  • 3. Thiopurine biology and pharmacology.
    Aarbakke J; Janka-Schaub G; Elion GB
    Trends Pharmacol Sci; 1997 Jan; 18(1):3-7. PubMed ID: 9114722
    [No Abstract]   [Full Text] [Related]  

  • 4. Thiopurine methyl transferase: activity and genotyping in patients with acute lymphoblastic leukemia.
    Brouwer C; Keizer-Garritsen JJ; Lambooy LH; Ament K; Ter Riet PG; De Abreu RA; Bökkerink JP; Van Wering ER; Van Der Does-Van Den Berg A; Veerman AJ; Trijbels JP
    Adv Exp Med Biol; 2000; 486():327-31. PubMed ID: 11783509
    [No Abstract]   [Full Text] [Related]  

  • 5. Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia.
    Lennard L; Gibson BE; Nicole T; Lilleyman JS
    Arch Dis Child; 1993 Nov; 69(5):577-9. PubMed ID: 8257179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Susceptibility to 6-mercaptopurine toxicity related with NUDT15 and ABCC4 variants in Japanese childhood acute lymphoblastic leukemia].
    Tanaka Y
    Rinsho Ketsueki; 2017; 58(8):950-956. PubMed ID: 28883280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe 6-thioguanine-induced marrow aplasia in a child with acute lymphoblastic leukemia and inherited thiopurine methyltransferase deficiency.
    McBride KL; Gilchrist GS; Smithson WA; Weinshilboum RM; Szumlanski CL
    J Pediatr Hematol Oncol; 2000; 22(5):441-5. PubMed ID: 11037857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent mercaptopurine-induced acute pancreatitis: a rare complication of chemotherapy for acute lymphoblastic leukemia in children.
    Willert JR; Dahl GV; Marina NM
    Med Pediatr Oncol; 2002 Jan; 38(1):73-4. PubMed ID: 11835247
    [No Abstract]   [Full Text] [Related]  

  • 9. Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial.
    Vora A; Mitchell CD; Lennard L; Eden TO; Kinsey SE; Lilleyman J; Richards SM; ;
    Lancet; 2006 Oct; 368(9544):1339-48. PubMed ID: 17046466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus.
    Relling MV; Hancock ML; Rivera GK; Sandlund JT; Ribeiro RC; Krynetski EY; Pui CH; Evans WE
    J Natl Cancer Inst; 1999 Dec; 91(23):2001-8. PubMed ID: 10580024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of polymorphisms in transporter genes on dosing, efficacy and toxicity of maintenance therapy in children with acute lymphoblastic leukemia.
    Gervasini G; de Murillo SG; Jiménez M; de la Maya MD; Vagace JM
    Gene; 2017 Sep; 628():72-77. PubMed ID: 28710036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualized 6-mercaptopurine increments in consolidation treatment of childhood acute lymphoblastic leukemia: A NOPHO randomized controlled trial.
    Tulstrup M; Frandsen TL; Abrahamsson J; Lund B; Vettenranta K; Jonsson OG; Marquart HVH; Albertsen BK; Heyman M; Schmiegelow K
    Eur J Haematol; 2018 Jan; 100(1):53-60. PubMed ID: 28983968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeat-positive SARS-CoV-2 in a child with cancer.
    Radhakrishnan V; Gangopadhyay D
    Pediatr Blood Cancer; 2021 Mar; 68(3):e28744. PubMed ID: 33009874
    [No Abstract]   [Full Text] [Related]  

  • 14. [Research advances in pharmacogenomics of mercaptopurine].
    Chen XX; Shen SH
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Sep; 19(9):1027-1033. PubMed ID: 28899477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activity of the inosine triphosphate pyrophosphatase affects toxicity of 6-mercaptopurine during maintenance therapy for acute lymphoblastic leukemia in Japanese children.
    Tanaka Y; Manabe A; Nakadate H; Kondoh K; Nakamura K; Koh K; Utano T; Kikuchi A; Komiyama T
    Leuk Res; 2012 May; 36(5):560-4. PubMed ID: 22200619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond.
    Karas-Kuzelicki N; Mlinaric-Rascan I
    Pharmacogenomics; 2009 Aug; 10(8):1309-22. PubMed ID: 19663675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TPMT and NUDT15 genes are both related to mercaptopurine intolerance in acute lymphoblastic leukaemia patients from Uruguay.
    Soler AM; Olano N; Méndez Y; Lopes A; Silveira A; Dabezies A; Castillo L; da Luz JA
    Br J Haematol; 2018 Apr; 181(2):252-255. PubMed ID: 28146264
    [No Abstract]   [Full Text] [Related]  

  • 18. Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia.
    Stanulla M; Schaeffeler E; Flohr T; Cario G; Schrauder A; Zimmermann M; Welte K; Ludwig WD; Bartram CR; Zanger UM; Eichelbaum M; Schrappe M; Schwab M
    JAMA; 2005 Mar; 293(12):1485-9. PubMed ID: 15784872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of folate metabolic enzymes and toxicities of high dose methotrexate in children with acute lymphoblastic leukemia.
    Pakakasama S; Kanchanakamhaeng K; Kajanachumpol S; Udomsubpayakul U; Sirachainan N; Thithapandha A; Hongeng S
    Ann Hematol; 2007 Aug; 86(8):609-11. PubMed ID: 17323057
    [No Abstract]   [Full Text] [Related]  

  • 20. Veno-occlusive disease in patients receiving thiopurines during maintenance therapy for childhood acute lymphoblastic leukaemia.
    Stoneham S; Lennard L; Coen P; Lilleyman J; Saha V
    Br J Haematol; 2003 Oct; 123(1):100-2. PubMed ID: 14510948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.